Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort study.

World journal of gastroenterology - 7 Dec 2013

Li Lei, Liu Wei, Chen Yu-Han, Fan Chun-Lei, Dong Pei-Ling, Wei Fei-Li, Li Bing, Chen De-Xi, Ding Hui-Guo

Abstract excerpt

AIM: To study the clinical outcome of antiviral therapy in hepatitis B-related decompensated cirrhotic patients. METHODS: Three hundred and twelve patients with decompensated hepatitis B cirrhosis were evaluated in a prospective cohort. With two years of follow-up, 198 patients in the group recei...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Drug Resistance, Viral
Share to Hepatitis B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Kaplan-Meier Estimate

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Treatment Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 24363530
DOI: 10.3748/wjg.v19.i45.8373
PMCID: PMC3857462

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24363530-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort study.PMID 24363530Read ↗

Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.Semantic proximity Read ↗

Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014).Semantic proximity Read ↗

[Analysis of risk factors for drug resistant mutations in the reverse transcriptase region in chronic hepatitis B virus-infected patients].Semantic proximity Read ↗

Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.Semantic proximity Read ↗

Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.Semantic proximity Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Antiviral drug resistance: clinical consequences and molecular aspects.Semantic proximity Read ↗

Accumulation of mutations in reverse transcriptase of hepatitis B virus is associated with liver disease severity in treatment-naïve Chinese patients with chronic hepatitis B.Semantic proximity Read ↗

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients.Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of HBV in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.Semantic proximity Read ↗

Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.